RISPERIDONE-INDUCED NEUROLEPTIC MALIGNANT SYNDROME : A CASE REPORT

A young male schizophrenic presented with neuroleptic malignant syndrome (NMS). Risperidone was the probable precipitating agent. Rigidity and elevated CPK levels poorly responded to bromocriptine, but showed good response to dantrolene. The role of specific treatment and the differential response o...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkatasubramanian, G., Yogananda, B.H., Gangadhar, B.N.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2000
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956992/
https://www.ncbi.nlm.nih.gov/pubmed/21407918
Descripción
Sumario:A young male schizophrenic presented with neuroleptic malignant syndrome (NMS). Risperidone was the probable precipitating agent. Rigidity and elevated CPK levels poorly responded to bromocriptine, but showed good response to dantrolene. The role of specific treatment and the differential response of the symptom clusters are discussed.

Ejemplares similares